Fingerprint
Dive into the research topics of 'The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
Paolo F. Caimi, Kirit M. Ardeshna, Erin Reid, Weiyun Ai, Matthew Lunning, Jasmine Zain, Melhem Solh, Brad S. Kahl, Mehdi Hamadani
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations